Courtesy: IndyStar: Eli Lilly and Co., is more than doubling its investment in its Boone County manufacturing site to increase production of ingredients in its blockbuster weight loss and diabetes drugs.

The expansion to produce the ingredients in Zepbound and Mounjaro will increase the cost of the project from $3.7 billion to $9 billion.

“Our business since then, continues to look very promising, both pipeline events but also the uptake of some of our newest medicines including Mounjaro and Zepbound, or weight loss medication,” David Ricks, the CEO of Lilly, said during an event Friday at the Indiana Global Economic Summit. “This is a $9 billion dollar investment for the company. That’s the largest in our history.”

The Lilly site will be based in the LEAP Lebanon Innovation and Research District, a planned tech and manufacturing hub in Boone County. Gov. Eric Holcomb and the state economic development department announced the district in 2022, highlighting the initial $2.1 billion the company committed for the then-600 acres project. Since then, plans for the project have grown twice.

Thank you for your upload